Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86 | 1 | 13 | 12 | 165 |
| Inventories | N/A | N/A | N/A | N/A | 50 |
| Other current assets | 0 | 1 | 55 | 9 | 54 |
| TOTAL | $86 | $2 | $68 | $21 | $269 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 8 | 10 | 11 |
| Other Non-Current Assets | 50 | 50 | 168 | 183 | 147 |
| TOTAL | $50 | $50 | $176 | $193 | $158 |
| Total Assets | $136 | $52 | $244 | $214 | $427 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 751 | 2,570 | 2,402 | 2,066 | 1,791 |
| Accounts payable and accrued liabilities | 774 | 730 | 672 | 608 | 612 |
| Accrued Expenses | 2,280 | 2,186 | 2,005 | 1,869 | 1,762 |
| Other current liabilities | 185 | 3 | 0 | 2 | 44 |
| TOTAL | $3,990 | $5,489 | $5,152 | $4,615 | $4,275 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,063 | 0 | 38 | 56 | 75 |
| TOTAL | $2,063 | $N/A | $38 | $56 | $75 |
| Total Liabilities | $6,053 | $5,489 | $5,190 | $4,671 | $4,350 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,605 | 1,605 | 1,605 | 1,605 | 1,605 |
| Retained earnings | -17,380 | -16,802 | -15,350 | -14,682 | -14,159 |
| TOTAL | $-5,917 | $-5,438 | $-4,945 | $-4,458 | $-3,923 |
| Total Liabilities And Equity | $136 | $52 | $244 | $214 | $427 |